COVID-19 preclinical drug development database
Name: Shampa Das
Email Address: firstname.lastname@example.org
Novel approaches are urgently required to establish effective clinical regimens for SARSCov- 2. Pharmacokinetics-pharmacodynamics (PK-PD) provides the tools to ensure the optimal dosing required is used. Hollow fibre infection models (HFIM) are widely used in antimicrobial drug development. Currently, there are no HFIM models of SARS-CoV-2 and no way to quickly identify regimens for new or repurposed antivirals.